Skip to main content
Top
Published in: Journal of Clinical Immunology 8/2021

01-11-2021 | Letter to Editor

Undetectable NK Cells due to the FCGR3A Variant, L66H, Which May Not Be Directly Disease-Causing

Authors: Neema Izadi, Miao Sun, Emily M. Mace, Maurice R. G. O’Gorman, Joseph A. Church

Published in: Journal of Clinical Immunology | Issue 8/2021

Login to get access

Excerpt

A baby girl born at 38 weeks of gestation with no perinatal complications was brought to our attention for possible severe combined immunodeficiency (SCID) because of low T cell receptor excision circles (TRECs) (11/mcL, reference range > 18) on newborn screen. Blood was collected for confirmatory flow cytometry and the absolute number of T cells was borderline low (2116/mcL, reference range 2500–5500) but sufficient to rule out SCID. However, her NK cell enumeration showed absent (< 1%) NK cells (CD3 CD56+ CD16+ by BD Biosciences 6-color TBNK, San Jose, CA). Subsequent testing at a local laboratory identified normal numbers of NK cells (26%), but at this laboratory, NK cells were defined as (CD3 CD56+ by locally derived reagents). Complete laboratory values can be found in Supplementary Table E1. We therefore pursued further testing to determine if CD16 was absent from the patient’s cells or if there was a lack of targeting by the specific anti-CD16 monoclonal antibody used. …
Appendix
Available only for authorised users
Literature
2.
go back to reference de Vries E, Koene HR, Vossen JM, et al. Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections. Blood. 1996;88(8):3022–7.CrossRefPubMed de Vries E, Koene HR, Vossen JM, et al. Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections. Blood. 1996;88(8):3022–7.CrossRefPubMed
6.
go back to reference Lenart M, Trzyna E, Rutkowska M, et al. The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism. Int J Mol Med. 2010;26(3):435–42.PubMed Lenart M, Trzyna E, Rutkowska M, et al. The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism. Int J Mol Med. 2010;26(3):435–42.PubMed
Metadata
Title
Undetectable NK Cells due to the FCGR3A Variant, L66H, Which May Not Be Directly Disease-Causing
Authors
Neema Izadi
Miao Sun
Emily M. Mace
Maurice R. G. O’Gorman
Joseph A. Church
Publication date
01-11-2021
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 8/2021
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-021-01122-3

Other articles of this Issue 8/2021

Journal of Clinical Immunology 8/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.